IMMUNOGEN INC (37)
Browse by Contract Category
Contracts
-
Inducement Equity Incentive Plan, as amended
(Filed With SEC on August 1, 2022)
-
License Agreement dated as of February 14, 2022 by and between the Registrant and Eli Lilly and Company
(Filed With SEC on May 6, 2022)
-
First Amendment to Agreements dated as of December 9, 2013 by and between the Registrant and Eli Lilly and Company
(Filed With SEC on February 28, 2022)
-
Underwriting Agreement dated December 1, 2021 by and among ImmunoGen, Inc. and Jefferies LLC and Cowen and Company, LLC, as representatives of the several underwriters named in...
(Filed With SEC on December 3, 2021)
-
Collaboration and License Agreement effective as of October 19, 2020 by and between the registrant and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a subsidiary of Huadong...
(Filed With SEC on March 1, 2021)
-
Eleventh Amendment to Lease dated as of February 27, 2019 by and between Bobson Norwood Commercial, LLC and the Registrant
(Filed With SEC on March 1, 2019)
-
Amended and Restated 2018 Employee, Director and Consultant Equity Incentive Plan
(Filed With SEC on June 17, 2022)
-
Compensation Policy for Non-Employee Directors, as amended through December 16, 2021
(Filed With SEC on February 28, 2022)
-
Change in Control Severance Agreement dated November 15, 2021 between the Registrant and Kristen Harrington-Smith
(Filed With SEC on February 28, 2022)
-
Development and License Agreement with Biogen Idec., Inc. dated October 1, 2006
(Filed With SEC on February 28, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on December 3, 2021)
-
Securities Purchase Agreement dated August 11, 2021 between ImmunoGen, Inc. and RA Capital Healthcare Fund, L.P
(Filed With SEC on August 12, 2021)
-
Form of Pre-Funded Warrant
(Filed With SEC on August 12, 2021)
-
Compensation Policy for Non-Employee Directors, as amended through June 16, 2021
(Filed With SEC on June 17, 2021)
-
Amended and Restated 2018 Employee, Director and Consultant Equity Incentive Plan
(Filed With SEC on June 17, 2021)
-
Inducement Equity Incentive Plan, as amended
(Filed With SEC on May 10, 2021)
-
Change in Control Severance Agreement dated as of June 1, 2020 between the Registrant and Stacy Coen
(Filed With SEC on March 1, 2021)
-
Description of Securities
(Filed With SEC on March 1, 2021)
-
Open Market Sale AgreementSM, dated December 18, 2020, by and between ImmunoGen, Inc. and Jefferies LLC
(Filed With SEC on December 18, 2020)
-
Open Market Sale AgreementSM, dated September 25, 2020, by and between ImmunoGen, Inc. and Jefferies LLC
(Filed With SEC on September 25, 2020)
-
Change in Control Severance Agreement dated as of July 20, 2020 between the Registrant and Susan Altschuller, Ph.D
(Filed With SEC on August 5, 2020)
-
Employment Offer Letter dated June 30, 2020 between the Registrant and Susan Altschuller
(Filed With SEC on August 5, 2020)
-
Form of Performance-Based Stock Option Agreement (February 2020) under the Inducement Equity Incentive Plan
(Filed With SEC on August 5, 2020)
-
Inducement Equity Incentive Plan - as amended
(Filed With SEC on July 2, 2020)
-
Compensation Policy for Non-Employee Directors, as amended through June 17, 2020
(Filed With SEC on June 18, 2020)
-
Inducement Equity Incentive Plan as amended
(Filed With SEC on May 5, 2020)
-
Form of Performance-Based Stock Option Agreement dated February 7, 2020
(Filed With SEC on March 11, 2020)
-
First Amendment to Collaboration and Option Agreement dated as of November 20, 2019 by and between the Registrant and Jazz Pharmaceuticals Ireland Limited
(Filed With SEC on March 11, 2020)
-
Description of Securities
(Filed With SEC on March 11, 2020)
-
Underwriting Agreement dated January 22, 2020 by and among ImmunoGen, Inc. and Jefferies LLC, Cowen and Company, LLC and William Blair & Company, L.L.C., as representatives of the...
(Filed With SEC on January 23, 2020)
-
Form of Restricted Stock Unit Agreement under the Inducement Equity Incentive Plan
(Filed With SEC on December 20, 2019)
-
Form of Stock Option Agreement under the Inducement Equity Incentive Plan
(Filed With SEC on December 20, 2019)
-
Inducement Equity Incentive Plan
(Filed With SEC on December 20, 2019)
-
Employee Stock Purchase Plan, as amended through September 27, 2019
(Filed With SEC on November 5, 2019)
-
Severance Pay Plan for Vice Presidents and Higher, as amended through June 20, 2019
(Filed With SEC on August 7, 2019)
-
Form of Performance-Based Restricted Stock Agreement dated April 3, 2019
(Filed With SEC on May 7, 2019)
-
Royalty Purchase Agreement dated as of January 8, 2019 among the Registrant, Hurricane, LLC, Immunity Royalty Holdings, L.P., and OMERS IP Healthcare Holdings Limited
(Filed With SEC on March 1, 2019)
